172 related articles for article (PubMed ID: 17534158)
1. Insertional mutagenesis in gene therapy and stem cell biology.
Baum C
Curr Opin Hematol; 2007 Jul; 14(4):337-42. PubMed ID: 17534158
[TBL] [Abstract][Full Text] [Related]
2. Insertional mutagenesis and clonal dominance: biological and statistical considerations.
Fehse B; Roeder I
Gene Ther; 2008 Jan; 15(2):143-53. PubMed ID: 17972922
[TBL] [Abstract][Full Text] [Related]
3. Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: implications for the design of safer gene-based interventions in patients.
Romano G; Marino IR; Pentimalli F; Adamo V; Giordano A
Drug News Perspect; 2009 May; 22(4):185-96. PubMed ID: 19536363
[TBL] [Abstract][Full Text] [Related]
4. Concise review: managing genotoxicity in the therapeutic modification of stem cells.
Baum C; Modlich U; Göhring G; Schlegelberger B
Stem Cells; 2011 Oct; 29(10):1479-84. PubMed ID: 21898683
[TBL] [Abstract][Full Text] [Related]
5. Insertional mutagenesis by replication-deficient retroviral vectors encoding the large T oncogene.
Li Z; Kustikova OS; Kamino K; Neumann T; Rhein M; Grassman E; Fehse B; Baum C
Ann N Y Acad Sci; 2007 Jun; 1106():95-113. PubMed ID: 17395733
[TBL] [Abstract][Full Text] [Related]
6. Retroviral insertion site analysis in dominant haematopoietic clones.
Kustikova OS; Modlich U; Fehse B
Methods Mol Biol; 2009; 506():373-90. PubMed ID: 19110639
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
8. Murine leukemia following irradiation conditioning for transplantation of lentivirally-modified hematopoietic stem cells.
Siapati EK; Bigger BW; Kashofer K; Themis M; Thrasher AJ; Bonnet D
Eur J Haematol; 2007 Apr; 78(4):303-13. PubMed ID: 17378892
[TBL] [Abstract][Full Text] [Related]
9. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors.
Baum C; Kustikova O; Modlich U; Li Z; Fehse B
Hum Gene Ther; 2006 Mar; 17(3):253-63. PubMed ID: 16544975
[TBL] [Abstract][Full Text] [Related]
10. Mutational effects of retrovirus insertion on the genome of V79 cells by an attenuated retrovirus vector: implications for gene therapy.
Themis M; May D; Coutelle C; Newbold RF
Gene Ther; 2003 Sep; 10(19):1703-11. PubMed ID: 12923569
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell gene therapy: dead or alive?
Ferguson C; Larochelle A; Dunbar CE
Trends Biotechnol; 2005 Dec; 23(12):589-97. PubMed ID: 16216357
[TBL] [Abstract][Full Text] [Related]
12. Development of an in vitro cell culture assay system for measuring the activation of a neighbouring gene by the retroviral vector.
Hong Y; Yu SS; Yoon NK; Kang SJ; Lee JT; Kim S; Kim JM; Lee K; Jang JW; Kim S
J Gene Med; 2008 Aug; 10(8):847-54. PubMed ID: 18563862
[TBL] [Abstract][Full Text] [Related]
13. Retroviral integration site analysis in hematopoietic stem cells.
Kustikova OS; Baum C; Fehse B
Methods Mol Biol; 2008; 430():255-67. PubMed ID: 18370305
[TBL] [Abstract][Full Text] [Related]
14. Modern genome-wide genetic approaches to reveal intrinsic properties of stem cells.
de Haan G; Gerrits A; Bystrykh L
Curr Opin Hematol; 2006 Jul; 13(4):249-53. PubMed ID: 16755221
[TBL] [Abstract][Full Text] [Related]
15. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
Neschadim A; McCart JA; Keating A; Medin JA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis by retroviral transgene insertion: risk assessment and potential alternatives.
Baum C; Fehse B
Curr Opin Mol Ther; 2003 Oct; 5(5):458-62. PubMed ID: 14601513
[TBL] [Abstract][Full Text] [Related]
17. The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors.
Wilson CA; Cichutek K
Methods Mol Biol; 2009; 506():477-88. PubMed ID: 19110646
[TBL] [Abstract][Full Text] [Related]
18. Applying a "double-feature" promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery.
Orbán TI; Apáti A; Németh A; Varga N; Krizsik V; Schamberger A; Szebényi K; Erdei Z; Várady G; Karászi E; Homolya L; Német K; Gócza E; Miskey C; Mátés L; Ivics Z; Izsvák Z; Sarkadi B
Stem Cells; 2009 May; 27(5):1077-87. PubMed ID: 19415778
[TBL] [Abstract][Full Text] [Related]
19. Gene trapping in embryonic stem cells.
Stanford WL; Epp T; Reid T; Rossant J
Methods Enzymol; 2006; 420():136-62. PubMed ID: 17161697
[TBL] [Abstract][Full Text] [Related]
20. Insertional mutagenesis in mice: new perspectives and tools.
Carlson CM; Largaespada DA
Nat Rev Genet; 2005 Jul; 6(7):568-80. PubMed ID: 15995698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
